Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Shares of Intra-Cellular Therapies, Inc. (ITCI) are down more than 10% Monday morning on missing second-quarter results.


RTTNews | Aug 10, 2020 10:21AM EDT

10:20 Monday, August 10, 2020 (RTTNews.com) - Shares of Intra-Cellular Therapies, Inc. (ITCI) are down more than 10% Monday morning on missing second-quarter results.

The Company reported a net loss of $63.7 million, or $0.96 per share for the second quarter compared to a net loss of $37.4 million, or $0.68 per share in the year-ago period. On average, analysts polled by Thomson Reuters expected the company to report loss of $0.91 per share.

Net product sales were $1.9 million in the quarter, missing the consensus estimate of $3.03 million.

Intra-Cellular Therapies stock is currently trading at $18.64. It has traded in the range of $6.75- $43.56 in the last 52 weeks.

Read the original article on RTTNews ( https://www.rttnews.com/3120102/stock-alert-ntra-cellular-therapies-drops-10.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC